RxDoctor Payments Data

Thomas Brandeisky, DO

Facial Plastic Surgery · Brick, NJNPI 1306816301

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 108 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 34.5% of the total. Reporting peaked in 2022 at $887 and has fallen 57.7% since, to $375 in 2025.

$3,095in general payments, 2019–2025

Across 108 payments — averaging $28.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$1K
  • GSK$425
  • Sanofi$370
  • Regeneron Healthcare Solutions, Inc.$298
  • Intersect ENT, Inc.$184
  • Stryker$132
  • plus $617 from 11 others

What the payments were for

  • Food & beverage$3,095100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,095 in reported general payments places this provider in the 75th percentile of 22 facial plastic surgery providers in New Jersey.

See all facial plastic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$156,255
Medicare patients
609
Services billed
1,412

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab14$79,196
Ipratropium Bromide146$3,296
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort53$2,669
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth14$1,526
Famotidine85$1,123
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav70$604
Levocetirizine Dihydrochloride25$477
Methylprednisolone21$169
Fluticasone Propionate12$164
Doxycycline Hyclate14$137
Omeprazole13$123
Hydrocortisone22$115
Prednisone16$81
Amoxicillin12$39

Paid to pharmacies, not to this prescriber.

Other facial plastic surgery in Brick

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →